South Africa has been investing in efforts to identify potential blood stem cell donors, but this investment has not been consistently matched by funding for the critical pathways that enable these donor matches to result in life-saving transplants. This situation notes a fundamental challenge within the healthcare system, where significant resources are allocated to one key aspect of treatment without adequate support for the subsequent steps. The disparity means that while donor registries grow, the practical ability to perform transplants for eligible blood cancer patients remains constrained, leaving many without access to the life-saving procedures they need. South Africa, therefore, is actively investing in finding donors without consistently financing the pathway that allows those matches to ultimately save lives.
The Donor Pool Paradox
DKMS Africa has registered more than 200,000 potential donors over the past five years, significantly contributing to the available pool for blood stem cell transplants. This substantial effort has expanded the base of individuals willing to donate, which is a vital first step in addressing the needs of blood cancer patients. The organization's commitment to broadening the donor pool is evident in its continuous registration drives and public awareness campaigns. A 2025 study conducted by DKMS, which analyzed HLA (Human Leukocyte Antigen) data from 56,961 South African potential donors registered between 2019 and 2024, revealed important insights into donor-patient matching probabilities. The study found that black African and white patients exhibited similar matching probabilities when both donors and patients belonged to the same population group, showing the importance of diverse donor registries. The study further modeled that increasing the number of registered black African potential donors to one million could provide black African patients with an 80% probability of identifying at least one fully matched donor, demonstrating the immense potential of expanding targeted donor recruitment.
Systemic Barriers to Treatment
Despite the growing donor pool, several systemic challenges impede South African blood cancer patients from accessing necessary transplants. These barriers often create a complex web of obstacles that prevent timely and effective treatment. Late diagnosis is a widespread issue, often leading to more advanced disease stages where treatment options become limited and outcomes less favorable. Fragmented referral systems further complicate matters, causing delays in patients reaching appropriate specialist care. Delayed testing, including critical HLA typing, can also prolong the waiting period for a suitable donor match. Beyond these initial hurdles, the healthcare infrastructure itself presents significant limitations. Limited specialist capacity, particularly for highly specialized procedures like blood stem cell transplants, means that even when a match is found, there may not be enough trained personnel to perform the procedure. The unavailability of transplant beds in hospitals further constrains the healthcare system's ability to perform these procedures, creating bottlenecks in the treatment pathway. Additionally, unaffordable treatment costs represent a significant barrier for many patients, especially in a country with high levels of socioeconomic disparity, effectively putting life-saving care out of reach for a substantial portion of the population.
These local challenges are exacerbated by broader trends in global health funding. According to Africa CDC, development assistance for health to Africa decreased from $25.8-billion in 2021 to approximately $13-billion in 2025. This significant reduction in funding affects the broader healthcare infrastructure across the continent, impacting everything from primary care to specialized treatments like cancer therapy. This decline in international support comes despite the continent carrying a disproportionate burden of disease. Africa carries roughly 22% of the global burden of disease, yet it accounts for only 1% of global health expenditure, noting a substantial disparity in resource allocation that leaves healthcare systems under-resourced and vulnerable.
Pathways to Progress
To effectively address the needs of South African blood cancer patients, expanding the donor registry and financing access to transplantation must happen in tandem. These two components are interdependent, with growth in one area requiring corresponding support in the other to ensure patients ultimately benefit from the full spectrum of care. A holistic approach is essential, one that recognizes that identifying a donor is only the first step in a complex and costly process. The ultimate measure for budgets, partnerships, and accountability within the healthcare system should be the number of clinically eligible patients who successfully receive a transplant. This focus emphasizes the importance of a full strategy that extends beyond donor identification to encompass the full spectrum of care required for these life-saving procedures, from diagnosis and referral to the transplant itself and subsequent follow-up care. Only through such integrated efforts can South Africa truly bridge the gap and ensure that its blood cancer patients have equitable access to life-saving treatment.
